Irina Yurievna Ryadnova

Title: Irina Yurievna Ryadnova: Innovator in Pharmaceutical Sciences

Introduction

Irina Yurievna Ryadnova is a prominent inventor based in St. Petersburg, Russia. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cardiovascular and respiratory diseases. With a total of 2 patents, her work focuses on developing innovative peptide substances that restore organ functions.

Latest Patents

One of her latest patents is a peptide substance designed to restore myocardium function. This invention pertains to pharmaceutical means for treating cardiovascular diseases. It introduces a new tetrapeptide, alanyl-glutamyl-aspartyl-arginine, with the general formula Ala-Glu-Asp-Arg. This peptide reveals biological activity that aids in the restoration of myocardium function during treatment for various forms of this pathology. The pharmacological substance containing this tetrapeptide is intended to be included in medications to enhance heart function.

Another significant patent involves a peptide substance aimed at restoring respiratory organ functions. This invention addresses medicinal remedies for respiratory system diseases. It proposes a biologically active tetrapeptide, alanyl-glutamyl-aspartyl-leucine, with the general formula Ala-Glu-Asp-Leu. This substance is capable of restoring respiratory organ functions and is intended for use in medical preparations to treat different forms of lung pathology.

Career Highlights

Irina is currently associated with Access Bioscience Cjsc, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, particularly in the realm of peptide-based therapies.

Collaborations

Irina has collaborated with notable professionals in her field, including Vladimir Khatskelevich Khavinson and Galina Anatolievna Ryzhak. These collaborations have further enhanced her research and contributed to the advancement of her inventions.

Conclusion

Irina Yurievna Ryadnova is a trailblazer in the development of peptide substances for medical applications. Her patents reflect her commitment to improving health outcomes through innovative pharmaceutical solutions. Her work continues to inspire advancements in the treatment of cardiovascular and respiratory diseases.